
PharmAust accelerates MPL clinical trials in fights against Covid and Motor Neuron Disease
PharmAust says it will expedite the Covid-19 trial of lead monepantel into Phase 2, which could facilitate faster recruitment. Clinical stage biotech PharmAust (ASX:PAA) has provided an update of its human clinical trials currently in progress. The company …